Janney Montgomery Scott LLC Has $7.81 Million Position in The Cooper Companies, Inc. (NASDAQ:COO)

Janney Montgomery Scott LLC reduced its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 4.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 92,633 shares of the medical device company's stock after selling 4,652 shares during the quarter. Janney Montgomery Scott LLC's holdings in Cooper Companies were worth $7,814,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of COO. OFI Invest Asset Management bought a new position in Cooper Companies in the fourth quarter valued at approximately $34,000. City Holding Co. bought a new position in Cooper Companies in the first quarter valued at approximately $34,000. New Age Alpha Advisors LLC bought a new position in Cooper Companies in the fourth quarter valued at approximately $38,000. Covestor Ltd boosted its stake in Cooper Companies by 35.5% in the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after acquiring an additional 120 shares during the last quarter. Finally, Atala Financial Inc bought a new position in Cooper Companies in the fourth quarter valued at approximately $51,000. 24.39% of the stock is owned by institutional investors.

Cooper Companies Stock Performance

Shares of COO stock traded down $0.34 during midday trading on Friday, hitting $69.47. 4,618,261 shares of the company were exchanged, compared to its average volume of 1,649,399. The firm has a market capitalization of $13.89 billion, a P/E ratio of 17.91, a PEG ratio of 1.69 and a beta of 0.98. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10. The firm's 50 day moving average price is $77.28 and its two-hundred day moving average price is $85.06. The Cooper Companies, Inc. has a 52 week low of $65.00 and a 52 week high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.93 by $0.03. The business had revenue of $1 billion during the quarter, compared to the consensus estimate of $995.12 million. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. Cooper Companies's revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.85 EPS. As a group, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on COO shares. Wall Street Zen cut shares of Cooper Companies from a "buy" rating to a "hold" rating in a research report on Saturday, June 7th. Citigroup reduced their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Needham & Company LLC raised shares of Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 price target on the stock in a research report on Tuesday, June 17th. Finally, Robert W. Baird reduced their price target on shares of Cooper Companies from $107.00 to $97.00 and set an "outperform" rating on the stock in a research report on Friday, May 30th. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $99.70.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.